Sunil Healthcare Share Price
Sector: Biotechnology & Drugs
83.00 +3.99 (5.05%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
80.00
Today’s High
83.00
52 Week Low
60.55
52 Week High
104.00
Key Metrics
- Market Cap (In Cr) 85.12
- Beta 0.65
- Div. Yield (%) 0
- P/B 1.27
- TTM P/E -
- Sector P/E 0
- D/E 0.01
- Open Price 80
- Prev Close 79.01
Sunil Healthcare Analysis
Price Analysis
-
1 Week3.45%
-
3 Months26.24%
-
6 Month5.89%
-
YTD5.95%
-
1 Year-5.29%
Risk Meter
- 66% Low risk
- 66% Moderate risk
- 66% Balanced Risk
- 66% High risk
- 66% Extreme risk
Sunil Healthcare News
Sunil Singhania's Abakkus picks stake in TTK Healthcare via block deal
1 min read . 24 Mar 2023Religare Finvest case: Delhi HC notice to ED on Shivinder Singh’s bail plea
1 min read . 22 Jun 2020Sunil Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 83.42
- Selling/ General/ Admin Expenses Total
- 11.8
- Depreciation/ Amortization
- 6.35
- Other Operating Expenses Total
- 24.69
- Total Operating Expense
- 79.51
- Operating Income
- 3.91
- Net Income Before Taxes
- -1.22
- Net Income
- -1.42
- Diluted Normalized EPS
- -1.38
- Period
- 2025
- Total Assets
- 161.94
- Total Liabilities
- 94.88
- Total Equity
- 67.07
- Tangible Book Valueper Share Common Eq
- 65.36
- Period
- 2025
- Cashfrom Operating Activities
- 11.52
- Cashfrom Investing Activities
- -7.7
- Cashfrom Financing Activities
- -3.87
- Net Changein Cash
- -0.05
- Period
- 2024
- Total Revenue
- 90.19
- Selling/ General/ Admin Expenses Total
- 12.94
- Depreciation/ Amortization
- 6.09
- Other Operating Expenses Total
- 26.61
- Total Operating Expense
- 92.02
- Operating Income
- -1.83
- Net Income Before Taxes
- -2.56
- Net Income
- -1.78
- Diluted Normalized EPS
- -1.63
- Period
- 2024
- Total Assets
- 158.5
- Total Liabilities
- 90.28
- Total Equity
- 68.22
- Tangible Book Valueper Share Common Eq
- 66.44
- Period
- 2024
- Cashfrom Operating Activities
- -15.4
- Cashfrom Investing Activities
- -10.11
- Cashfrom Financing Activities
- 25
- Net Changein Cash
- -0.51
- Period
- 2023
- Total Revenue
- 110.49
- Selling/ General/ Admin Expenses Total
- 14.78
- Depreciation/ Amortization
- 7.01
- Other Operating Expenses Total
- 32.33
- Total Operating Expense
- 101.34
- Operating Income
- 9.15
- Net Income Before Taxes
- 9.48
- Net Income
- 6.68
- Diluted Normalized EPS
- 6.45
- Period
- 2023
- Total Assets
- 120.79
- Total Liabilities
- 64.79
- Total Equity
- 56
- Tangible Book Valueper Share Common Eq
- 54.49
- Period
- 2023
- Cashfrom Operating Activities
- 7.47
- Cashfrom Investing Activities
- -3.4
- Cashfrom Financing Activities
- -3.75
- Net Changein Cash
- 0.32
- Period
- 2022
- Total Revenue
- 119.16
- Selling/ General/ Admin Expenses Total
- 14.19
- Depreciation/ Amortization
- 6.31
- Other Operating Expenses Total
- 39.14
- Total Operating Expense
- 108.08
- Operating Income
- 11.08
- Net Income Before Taxes
- 9.26
- Net Income
- 6.42
- Diluted Normalized EPS
- 6.26
- Period
- 2022
- Total Assets
- 109.69
- Total Liabilities
- 59.74
- Total Equity
- 49.95
- Tangible Book Valueper Share Common Eq
- 48.55
- Period
- 2022
- Cashfrom Operating Activities
- 22.51
- Cashfrom Investing Activities
- -4.24
- Cashfrom Financing Activities
- -18.56
- Net Changein Cash
- -0.29
- Period
- 2021
- Total Revenue
- 90.29
- Selling/ General/ Admin Expenses Total
- 12.3
- Depreciation/ Amortization
- 6.11
- Other Operating Expenses Total
- 29.94
- Total Operating Expense
- 91.06
- Operating Income
- -0.76
- Net Income Before Taxes
- -0.55
- Net Income
- -0.64
- Diluted Normalized EPS
- -0.58
- Period
- 2021
- Total Assets
- 120.56
- Total Liabilities
- 76.85
- Total Equity
- 43.72
- Tangible Book Valueper Share Common Eq
- 42.44
- Period
- 2021
- Cashfrom Operating Activities
- 16.99
- Cashfrom Investing Activities
- -11.36
- Cashfrom Financing Activities
- -6.42
- Net Changein Cash
- -0.79
- Period
- 2020
- Total Revenue
- 70.02
- Selling/ General/ Admin Expenses Total
- 13.02
- Depreciation/ Amortization
- 6.13
- Other Operating Expenses Total
- 32.75
- Total Operating Expense
- 80.47
- Operating Income
- -10.45
- Net Income Before Taxes
- -3
- Net Income
- -4.96
- Diluted Normalized EPS
- -2.14
- Period
- 2020
- Total Assets
- 130.23
- Total Liabilities
- 85.63
- Total Equity
- 44.6
- Tangible Book Valueper Share Common Eq
- 43.25
- Period
- 2020
- Cashfrom Operating Activities
- 4.31
- Cashfrom Investing Activities
- -2.52
- Cashfrom Financing Activities
- -1.56
- Net Changein Cash
- 0.23
- Period
- 2019
- Total Revenue
- 80.88
- Selling/ General/ Admin Expenses Total
- 12.57
- Depreciation/ Amortization
- 5.74
- Other Operating Expenses Total
- 28.55
- Total Operating Expense
- 75.29
- Operating Income
- 5.59
- Net Income Before Taxes
- -0.81
- Net Income
- -0.69
- Diluted Normalized EPS
- -0.6
- Period
- 2019
- Total Assets
- 137.73
- Total Liabilities
- 90.96
- Total Equity
- 46.77
- Tangible Book Valueper Share Common Eq
- 45.3
- Period
- 2019
- Cashfrom Operating Activities
- 14.73
- Cashfrom Investing Activities
- -2.8
- Cashfrom Financing Activities
- -11.63
- Net Changein Cash
- 0.3
- Period
- 2025-03-31
- Total Revenue
- 21.2
- Selling/ General/ Admin Expenses Total
- 3.09
- Depreciation/ Amortization
- 1.68
- Other Operating Expenses Total
- 5.96
- Total Operating Expense
- 19.85
- Operating Income
- 1.35
- Net Income Before Taxes
- 0.28
- Net Income
- 0.36
- Diluted Normalized EPS
- 0.35
- Period
- 2025-03-31
- Total Assets
- 161.94
- Total Liabilities
- 94.88
- Total Equity
- 67.07
- Tangible Book Valueper Share Common Eq
- 65.36
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 11.52
- Cashfrom Investing Activities
- -7.7
- Cashfrom Financing Activities
- -3.87
- Net Changein Cash
- -0.05
- Period
- 2024-12-31
- Total Revenue
- 20.46
- Selling/ General/ Admin Expenses Total
- 2.95
- Depreciation/ Amortization
- 1.69
- Other Operating Expenses Total
- 6.33
- Total Operating Expense
- 19.45
- Operating Income
- 1.02
- Net Income Before Taxes
- -0.34
- Net Income
- -0.54
- Diluted Normalized EPS
- -0.53
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 20.26
- Selling/ General/ Admin Expenses Total
- 2.85
- Depreciation/ Amortization
- 1.51
- Other Operating Expenses Total
- 6.2
- Total Operating Expense
- 19.45
- Operating Income
- 0.81
- Net Income Before Taxes
- -0.51
- Net Income
- -0.55
- Diluted Normalized EPS
- -0.53
- Period
- 2024-09-30
- Total Assets
- 158.86
- Total Liabilities
- 91.36
- Total Equity
- 67.5
- Tangible Book Valueper Share Common Eq
- 65.77
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 12.01
- Cashfrom Investing Activities
- -4.22
- Cashfrom Financing Activities
- -7.67
- Net Changein Cash
- 0.13
- Period
- 2024-06-30
- Total Revenue
- 21.5
- Selling/ General/ Admin Expenses Total
- 2.91
- Depreciation/ Amortization
- 1.48
- Other Operating Expenses Total
- 6.2
- Total Operating Expense
- 20.77
- Operating Income
- 0.73
- Net Income Before Taxes
- -0.65
- Net Income
- -0.69
- Diluted Normalized EPS
- -0.67
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 21.31
- Selling/ General/ Admin Expenses Total
- 3.04
- Depreciation/ Amortization
- 1.43
- Other Operating Expenses Total
- 6.48
- Total Operating Expense
- 20.07
- Operating Income
- 1.24
- Net Income Before Taxes
- 0.17
- Net Income
- 0.16
- Diluted Normalized EPS
- 0.15
- Period
- 2024-03-31
- Total Assets
- 158.5
- Total Liabilities
- 90.28
- Total Equity
- 68.22
- Tangible Book Valueper Share Common Eq
- 66.44
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -15.4
- Cashfrom Investing Activities
- -10.11
- Cashfrom Financing Activities
- 25
- Net Changein Cash
- -0.51
- Period
- 2023-12-31
- Total Revenue
- 22.67
- Selling/ General/ Admin Expenses Total
- 3.32
- Depreciation/ Amortization
- 1.45
- Other Operating Expenses Total
- 6.26
- Total Operating Expense
- 24.75
- Operating Income
- -2.08
- Net Income Before Taxes
- -0.39
- Net Income
- -0.2
- Diluted Normalized EPS
- -0.2
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Sunil Healthcare Technical
Moving Average
SMA
- 5 Day80.28
- 10 Day80.63
- 20 Day78.3
- 50 Day75.99
- 100 Day73.8
- 300 Day78.61
Sunil Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Source Natural Foods & Herb Supl
- 158.75
- -4.65
- -2.85
- 269.75
- 105.2
- 103.55
- Achyut Healthcare
- 3.65
- 0.11
- 3.11
- 6.25
- 2.82
- 85.98
- Sunil Healthcare
- 83
- 3.99
- 5.05
- 104
- 60.55
- 85.12
- Remedium Lifecare
- 0.95
- 0.04
- 4.4
- 15.13
- 0.8
- 83.79
- Biofil Chemicals And Pharma
- 47.4
- -0.09
- -0.19
- 92
- 40.5
- 75.68
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Source Natural Foods & Herb Supl
- 35.2
- 4.57
- 15.33
- 9.08
- Achyut Healthcare
- 182.5
- 2.75
- -
- -
- Sunil Healthcare
- -
- 1.27
- 3.38
- 1.88
- Remedium Lifecare
- 27.22
- 1.25
- -
- -
- Biofil Chemicals And Pharma
- 138.65
- 4.08
- 4.42
- 2.33
Sunil Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 13-Feb-25
- Quarterly Results
- 13-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results & A.G.M.
- 28-May-24
- Audited Results
- 14-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 29-May-23
- Audited Results
- 14-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 27-Mar-25
- 21-Feb-25
- POM
- 30-Sept-24
- 16-Sept-24
- AGM
- 08-Jan-24
- 06-Dec-23
- POM
- 27-Sept-23
- 14-Aug-23
- AGM
- 21-Jun-22
- 18-May-22
- POM
- 28-Sept-21
- 22-Jul-21
- AGM



